This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Business Development Remove Genetic Disease Remove Reagent Related Topics
In-Vivo Drug Delivery In-Vitro Genetics Pharma Companies Regulation DNA Clinical Trials Doctors Licensing More Related Topics >
article thumbnail

What challenges does the advanced therapies sector face? 

Drug Discovery World

JANUARY 30, 2024

Dr Naldini open new doors for cures for otherwise untreatable genetic diseases with the full impact of his work still untapped”, she said. High-cost materials: Specialised equipment, reagents, and cell culture media significantly contribute to the overall cost. Developing more efficient and affordable alternatives is key.

Gene Therapy 72
Gene Therapy Manufacturing Gene Clinical Trials 72
article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

OCTOBER 1, 2020

Dr. Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. Working on finding therapies for genetic diseases at NeuBase, Dr. Sooter says, “Everyday, we get up and that’s our goal and it really drives everyone.

Scientist 52
Scientist In-Vitro Research Life Science 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024